Navigation Links
Wockhardt honoured with 2012 DIANA Award for Best Overall Generic Manufacturer
Date:6/15/2012

PARSIPPANY, N.J., June 15, 2012 /PRNewswire/ -- Pharmaceutical and biotechnology major Wockhardt announced that its US subsidiary, Wockhardt USA LLC was honoured with the presentation of the 2012 DIANA Award by the Healthcare Distribution Management Association (HDMA) for the 'Best Overall Generic Product Manufacturer' with sales of up to USD 100 million in the healthcare distributor market at their prestigious annual Business & Leadership Conference in San Antonio, Texas.

(Photo: http://photos.prnewswire.com/prnh/20120615/NY25710LOGO )

The Distribution Industry Awards for Notable Achievements in Healthcare (DIANA) Award is presented by HDMA to companies that continually foster strong trading partner relationships with the Association's primary distributor members by creating exceptional business practices that advance trade relations and benefit the entire healthcare supply chain.

"This award from HDMA is particularly significant and encouraging to Wockhardt's efforts in building strong relationships with our distributors and partners," said Wockhardt's Founder Chairman & Group CEO, Dr. Habil Khorakiwala.  "We are indeed honoured and elated with this recognition from HDMA," he further added.

About Wockhardt:

Wockhardt is a high-technology intensive global pharmaceutical and biotechnology company with multi-disciplinary and innovative R&D programmes.  It has 3 research centres globally and manufacturing facilities across India, USA, UK and Ireland.

Wockhardt has a significant presence in USA, Europe and India, with 75% of its global revenues coming from international businesses. With a large pool of Patents and Intellectual Property knowhow, Wockhardt is home to 590 scientists, of whom 80 are doctorates.  In all, Wockhardt has 158 Patents granted worldwide.  In biotechnology research, it has built a competent 'Concept to Market' capabilities in all facets of development and manufacture of recombinant biopharmaceuticals.

Wockhardt boasts of a multi-ethnic workforce of more than 8000 people from 14 different nationalities.  For more information, please visit www.wockhardt.com

Contact information: 
Sunil Khera
President - The Americas
Wockhardt
+1 (973) 257-4960
SKhera@Wockhardt.com

 


'/>"/>
SOURCE Wockhardt
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
2. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
3. QBC Diagnostics Awarded GSA Contract
4. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
5. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. Hanger clinicians honored with 2012 Tribeca Disruptive Innovation Award
8. Northwest Bio Awarded $5.5 Million German Government Grant
9. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
10. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
11. Nominations Open for San Francisco Business Times Health Care Heroes Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... -- Exactly 50 years ago today, the Monterey Pop Festival opened ... the San Francisco "Summer of Love."  To celebrate the anniversary, ... in strategic market research portals that it will begin delivering ... Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, Embodied ... Startups pitch competition and came away with $25,000 ... is described by Forbes as "entering the life of ... Association as teaching "empathy to medical professionals in an ... was recently named a finalist for the Department of ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
Breaking Medicine Technology:
(Date:6/27/2017)... ... June 27, 2017 , ... ... appointment of Mike Finnegan to the position of Executive Vice President, Sales and ... in healthcare technology, telehealth and medical device sales leadership. He has received industry ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... many of the health care industry’s hospitals and provider groups, has announced that ... for select customers. Parasail Health is a San Francisco health-finance startup that has ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article ... reach a staggering $6.81 billion by the year 2024 according to a new report. ... rate than those made from titanium. Los Angeles area clinic Beverly Hills Periodontics & ...
(Date:6/27/2017)... ... June 27, 2017 , ... Atmosera , ... Atmosera Managed Azure Services . The trusted, transparent, and secure solution for the ... growing customer base. Atmosera’s next generation services include integrated capabilities for public, private, ...
(Date:6/27/2017)... ... June 27, 2017 , ... Today, June 27th is ... PTSD. Yet less than 20% will receive adequate care due to lack of effective ... receive any care at all. And left untreated, veterans are at an increased risk ...
Breaking Medicine News(10 mins):